Accumulating evidence from genome wide association studies (GWAS) suggests abundant presence of shared genetic influences among complex human traits and disorders. A major challenge that often limits our ability to detect and quantify shared genetic variation is that current methods of cross-trait analysis are not designed to work in scenarios with low or absent genetic correlation. Here we introduce a statistical tool BGMG (Bivariate Gaussian Mixture Model of GWAS) which can uncover various scenarios of genetic overlap regardless of genetic correlation, using GWAS summary statistics from studies with potentially shared participants. We perform extensive simulation on synthetic GWAS data to ensure that BGMG provides accurate estimates of model parameters in the presence of realistic linkage disequilibrium (LD) structure.
INTRODUCTION
In recent years, genome-wide association studies (GWASs) have successfully detected genetic variants associated with multiple complex human traits or disorders, providing important insights into human biology 1 . Understanding the degree to which complex human phenotypes share genetic influences is critical for identifying the etiology of phenotypic relationships, which can inform disease nosology, diagnostic practice and improve drug development. Most complex human phenotypes are known to have a polygenic architecture, i.e. their variation is influenced by many genetic variants. Given the large number of human phenotypes and the finite number of causal genetic variants, many variants are expected to influence more than one phenotype (i.e. exhibit allelic pleiotropy) 2, 3 . This has led to cross-trait analyses quantifying genetic overlap becoming a widespread endeavor in genetic research, made possible by the public availability of most GWAS summary statistics (p-values and z-scores) 4, 5 .
Currently, the prevailing measure to quantify genetic overlap is genetic correlation. The square of genetic correlation gives the proportion of variance that the two traits share due to genetic causes. The sign of genetic correlation indicates whether genetic effects in both traits are, predominantly, sharing the same or the opposite effect direction. Genetic correlation can be quantified from raw genotypes using restricted maximum likelihood 6 or polygenic risk scores 7, 8 ; from a set of singlenucleotide polymorphisms (SNPs) that pass genome-wide significance threshold using Mendelian Randomization 9 ; or from all SNPs, including those that do not reach genome-wide significance using Cross-Trait Linkage Disequilibrium Score Regression, LDSR 10 . A limitation to all these methods, however, is their inability to capture mixtures of effect directions across shared genetic variants. They only report overall positive, negative or no genetic correlation. Recent analyses suggest that across traits the correlation in the directionality and size of SNP effects is not the same for all mutually associated SNPs 10 (see Fig 1 for different cross-trait genetic relationships). This is exemplified by the genetic relationship between schizophrenia and cognitive function 11 . Despite consistent estimates of a negative genetic correlation between schizophrenia and different cognitive traits 12, 13 , a minority of genetic loci associated with both schizophrenia and cognitive traits show schizophrenia risk alleles associated with higher cognitive performance 11 . Moreover, recent analyses suggest that different complex phenotypes are influenced by different numbers of causal variants, i.e., some traits are more polygenic than others 14 , a concept in line with the endophenotype hypothesis 15 . To improve our understanding of the polygenic architecture of complex traits and their intricate relationships, new statistical tools are needed for quantification of genetic overlap.
Here we introduce the Bivariate Gaussian Mixture Model for GWAS (BGMG), which provides a measure of genetic overlap expressed as the proportion of SNPs associated with two traits. BGMG incorporates a causal mixture model 14 to yield a prior distribution of genetic effect sizes, and allows for overlapping samples. To estimate polygenic overlap, BGMG models true per-SNP effect sizes as a mixture of four bivariate normal distributions, illustrated in Fig 1: two causal components specific to each trait; one causal component of SNPs affecting both traits; and a null component of SNPs with no effect on either trait. Our statistical model provides a probability distribution function relating observed signed test statistics (GWAS zscores) to the underlying per-SNP effect sizes, incorporating effects of LD structure, minor allele frequency, sample size, cryptic relationships, and sample overlap, to capture all these effects on GWAS z-scores. The parameters of the mixture model are estimated from the summary statistics by direct optimization of the likelihood function.
We show in simulations that our model differentiates cross-trait scenarios with no polygenic overlap from scenarios with significant polygenic overlap, regardless of genetic correlation. We also show that BGMG estimates of genetic correlation are consistent with estimates of cross-trait LDSR and are not affected by sample overlap. Altogether, the results demonstrate the feasibility of BGMG for quantifying shared polygenic components influencing complex human phenotypes.
RESULTS

Overview of BGMG model
BGMG is based on the idea that at the causal level only a certain proportion of SNPs is associated with a trait of interest, while the remaining SNPs have no effect (mixture model). In a joint analysis of two traits we expect some SNPs to have an effect on both traits; some SNPs to have an effect on one trait but not the other; and the majority of SNPs to have no effect on either trait. In this context, the term "polygenic overlap" signifies the fraction of causal variants shared between traits, exceeding that expected by chance given the polygenicity of those traits. Based on these assumptions, BGMG models additive genetic effect sizes β1j, β2j of SNP j on the two traits as a mixture of four bivariate Gaussian components: 
where π1 and π2 are weights of the two components affecting the first and the second trait; π12 is a weighting of the component affecting both traits; and π0 is the fraction of SNPs that are null (non-causal) for both traits, 0 + 1 + 2 + 12 = 1; 1 2 and 2 2 control expected magnitudes of per-variant effect sizes; and ρ12 is the coefficient of genetic correlation, which is calculated from the subset of SNPs affecting both traits (see the Online Methods). Genome-wide genetic correlation rg is related to the parameter ρ12 as = 12 12 /√ 1 2 , where 1 and 2 indicate total (univariate) proportion of causal SNPs in each of the two traits ( 1 = 12 + 1 , 2 = 12 + 2 ). All parameters are assumed to be the same for all SNPs.
From the prior probability density function for association coefficients ( 1 , 2 ), we derive the likelihood term for observed GWAS signed test statistics, incorporating: effects of linkage disequilibrium structure (allelic correlation rij between variants i and j); heterozygosity ( = 2 (1 − ) where pj is the minor allele frequency of the j-th variant); number of subjects genotyped per variant (N1j and N2j); inflation due to cryptic relatedness 01 2 and 02 2 ; and inflation due to sample overlap ρ0. Specifically (see Supplementary Note),
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The nine parameters of the model ( 1 , 2 , 12 , 1 2 , 2 2 , 12 , 01 2 , 02 2 , 0 ) are fit by direct optimization of the weighted log likelihood, with weights inversely proportional to the LD score 16 . Confidence intervals for all parameters are estimated from the Observed Fishers Information matrix.
Forcing 12 = 1 (so that 0 = 1 = 2 = 0 ) reduces our model to the same assumptions as in cross-trait LD score regression 10 . Under this constraint our model predicts that GWAS signed test statistics follow bivariate Gaussian distribution with zero mean and variance-covariance matrix i.e., (z1j,z2j) ∼ N(0,Σj), where ℓ = ∑ 2 is the LD score (adjusted for heterozygosity). This model is in perfect agreement with cross-trait LD score regression, with expected chi square statistics ( 1 2 ) , ( 2 2 ) and cross-trait correlation ( 1 2 ) being proportional to the LD score of j-th SNP, and parameters 0 , 01 , 02 playing the role of LD score regression intercepts. The only distinction so far is that we choose to model effect sizes that are independent of allele frequency, leading to the incorporation of Hi in our model; this factor is absent from the LD score regression model due to the assumption there of effect sizes that are inversely proportional to Hi.
Relaxing the constraint π12 = 1, we find that estimating its value from the GWAS summary statistics never yields values exceeding ̂1 2 = 1%, across a wide range of complex traits. The fact that ̂1 2 is typically much less than 100% supports polygenic model and contradicts omnigenic model 17 . We show in simulations that under polygenic model the measure of π12, i.e., the proportion of causal variants affecting both traits, has both sensitivity and specificity in measuring genetic overlap.
Using GWAS summary statistics we find that some traits have a strong component of shared genetic effects but no genetic correlation. I.e., π12 significantly different from zero, but ρ12 is not. A challenge in detection and interpretation of such cases is that for polygenic traits we always expect a substantial portion of SNPs to have elevated test statistics in both traits due to LD with causal variants, even if no SNPs are causally affecting either trait. In our model, we account for this by modeling genetic effects at the causal level, and by reporting π12 as significant if it exceeds polygenic overlap that we expect by chance from the product 1 2 .
Simulations
We perform simulations to validate that the BGMG estimates of polygenic overlap (π12) are not affected by spurious association signals arising in large LD blocks, and that BGMG estimates of genetic correlation are not inflated by sample overlap. The simulations also allow us to compare BGMG estimates of genetic correlation with those of LDSR.
In all simulations we obtain synthetic GWAS results for a panel of N = 100,000 samples ("individuals"), generated by HapGen2 18 using 1000 Genomes 19 data to approximate the LD structure for European ancestry. For each simulation run we generated two quantitative traits for each individual by drawing effect sizes ( 1 , 2 ) from the four component mixture model (1), varying polygenicity of each phenotype ( 1 and 2 ), and polygenic overlap (π12). We choose polygenicity of each trait ranging from 10 −3 (high polygenicity) to 10 −4 (medium polygenicity) to 10 −5 (low polygenicity). We also choose between perfect polygenic overlap ( 12 = 1 ), partial polygenic overlap set to 10% of polygenicity of the traits ( 12 = 1 /10), and random polygenic overlap, which arise by chance if markers are spread randomly throughout the genome (independent prior probabilities, so that 12 = 1 2 ). In all simulations, we set narrow sense SNP heritability of each trait to h 2 = 0.5. Fig. 2 illustrates BGMG components for the four synthetic scenarios, introduced in Fig 1 , using 1 = 2 = 0.01% (medium polygenicity). The distribution of GWAS effect sizes, shown in Fig. 2 , is different from distribution of the causal effect sizes shown in Fig. 1 , and shows a much larger fraction of variants associated with the phenotype of interest, arising through LD. Table 2 . All discrepancies in polygenicity estimates ̂1 , ̂2 and ̂1 2 disappear in simulations without LD structure (see Supplementary Table 3 ).
In addition to point estimates of polygenicity we investigated BGMG performance using univariate quantile-quantile plots (QQ plots) on logarithmic scale, as shown in Supplementary Fig. 1 and 2 . The advantage of QQ plots is that they emphasize behavior in the tails of a distribution, and provide a valuable visual aid in showing how well a model fits data. The overall QQ plot ( Supplementary Fig 1) shows reasonably good fit across the entire range of p-values. QQ plots stratified by heterozygosity, , and LD score, ℓ, (Supplementary Fig 2) show minor mismatches for low values of and ℓ. Fig. 4 compares BGMG and LDSR estimates of genetic correlation and corresponding standard errors. These simulations cover scenarios with complete and partial polygenic overlap, using the same set of samples (N=100 000) to perform GWAS in both traits (i.e. we validate complete sample overlap). The results show that the estimates of genetic correlation from BGMG and LDSR are not biased by complete sample overlap. Error bars for BGMG are generally larger than LDSR because it estimates a larger set of parameters (9 parameters for BGMG model, 6 parameters for LDSR model).
DISCUSSION
Here we introduce BGMG, a new statistical tool for cross-trait analysis using GWAS summary statistics which builds on a Gaussian mixture modelling framework. BGMG offers two major advances compared to other currently available cross-trait analyses. First, BGMG allows for a mixture of same and opposite allelic effect directions among the shared genetic component, which is likely a pervasive occurrence given the large number of causal variants influencing traits and their distinct genetic etiologies [11] [12] [13] 20, 21 . Second, BGMG takes into account the unique polygenic architecture underlying each complex trait, which widely differs between traits, both in terms of the number of causal SNPs and the effect sizes of the causal SNPs 14, 22, 23 . Thus, BGMG enables a more complete quantification of polygenic overlap in various cross-trait scenarios than provided by other available tools estimating genetic overlap [7] [8] [9] [10] 24, 25 .
Using simulations, we show that BGMG robustly captures the degree of shared genetic components for various scenarios of polygenic overlap, with (Fig. 3) and without (Fig. 4) genetic correlation, and demonstrate that BGMG estimates are not inflated by sample overlap (Fig. 4) . Simulation results also reveal a small bias in polygenicity estimates (Supplementary Tables 1-4 ), which we expect to fix in our future work by more elaborate handling of the LD structure and switching our simulation pipeline to the standard GWAS association model which includes genetic covariates.
The BGMG model is based on a causal mixture model which gives a biologically more plausible prior distribution of genetic effect sizes compared to the "infinitesimal" model applied by other available cross-trait analyses 23, 26 . Causal mixture model is also known as a spike-and-slab distribution of effect sizes, and represents the most common way to perform simulations 10, 16, 27, 28 . A notable strength of the spike-and-slab model is the significant improvement of polygenic risk scores [29] [30] [31] .
Lack of correlation between two variables of course does not imply independence. By using simulated GWAS data, here we show that some scenarios of polygenic overlap not captured by genetic correlation tools are uncovered by BGMG (Fig. 4) . BGMG controls for the probability that some SNPs will, by chance or due to LD structure given high polygenicity, be jointly associated with two traits. In addition to offering insights into shared genetic architectures of complex traits, the BGMG modelling framework can be used to improve power for SNP discovery by estimating the posterior effect size of SNPs associated with one trait given the test statistics in another trait. Moreover, we expect that more accurately estimated effect sizes will improve predictive power of polygenic risk scores.
The BGMG model has some limitations. First, the model assumes similar LD structure among studies and is not currently applicable for analysis across different ethnicities. Second, the model assumes that causal variants are uniformly distributed across the genome. We plan to address this limitation by incorporating genomic annotations, known to be differentially enriched for true associations 32 . Third, individual parameters of the mixture model might have lower estimation accuracy than their combinations -for example, we observe larger estimation errors for 1 and 1 2 compared to the heritability estimate ℎ 2 ∝ 1 1 2 (due to inversely-correlated errors). Fourth, lack of significant estimates of polygenic overlap using BGMG does not exclude the possibility that some SNPs associations may indeed be linked to both traits, but less than expected by chance.
In conclusion, BGMG represents a useful addition to the tool-box for cross-trait GWAS analysis. By appropriately taking into account the intricate polygenic architectures of complex phenotypes BGMG allows for measures of polygenic overlap beyond genetic correlation. We expect this to lead to new insights into the pleiotropic nature of human genetic etiology. BGMG is available as a MATLAB/Octave package (see URLs; will be released after publication).
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FIGURES AND TABLES
Figure 1:
Components of causal mixture model in four extreme scenarios of polygenic overlap (synthetic data). Each point represents a SNP; horizontal and vertical axis show SNP causal effect sizes 1 , 2 on the first and on the second traits, respectively. Each component is simulated to have 0.01% of markers, randomly spread throughout the entire genome. Fig. 1A shows a scenario where causal variants do not overlap between the two traits. Fig. 1B shows an additional component of variants affecting both traits with the same (concordant) direction of effects. Fig. 1C adds a fourth component of markers that affect the two phenotypes in the opposite (discordant) direction. Finally, Fig. 1D shows a scenario similar to Estimates of polygenicity and polygenic overlap on synthetic data, in the absence of genetic correlation (ρ12 = 0). Rows correspond to three levels of polygenic overlap: perfect polygenic overlap ( 12 = 1 ), partial polygenic overlap equal to 10% of the polygenicity of the traits ( 12 = 1 /10), and random polygenic overlap, which arise by chance if markers are spread randomly throughout the genome ( 12 = 1 2 ). The simulations were performed with complete overlap of GWAS samples (N = 100,000), heritability h 2 of 0.5, and equal polygenicity in both traits ( = 1 = 2 ) ranging from 10 −3 (high polygenicity), 10 −4 (medium polygenicity) to 10 −5 (low polygenicity). The average of 10 simulations is shown with averaged estimated standard errors.
Figure 4:
Estimates of genetic correlation from Bivariate Mixture Model for GWAS (BGMG) and Cross-trait LD Score Regression (LDSR), with complete sample overlap (N = 100,000) and without sample overlap (N = 50,000 in each sample) between GWAS studies. In all simulations ρ12 is fixed at 0.5. Expected genome-wide genetic correlation is rg = 0.5 for complete polygenic overlap, and rg = 0.05 for partial polygenic overlap.
theory. The limitation of this method is that it is not suitable for parameters near their boundary, which is especially applicable to mixture weights 1 
For traits with K-fold difference in polygenicity ( 1 = 2 ) this formula predicts an upper bound on genome-wide genetic correlation: ≤ 12 /√ , where equality holds if causal variants of the less polygenic trait form a subset of the higher-polygenic trait markers.
Large LD blocks. We use inverse LD score weighting to avoid overcounting evidence from large LD blocks. An alternative approach, also available in the BGMG implementation, is to perform random pruning -a stochastic procedure that average log likelihood function across repeatedly selected subsets of variants such that for each pair of variants , ∈ the squared allelic correlation 2 falls below certain threshold. Given iterations of random pruning the log-likelihood function can be calculated as follows:
which is equivalent to weighted log-likelihood ( ) = ∑ log( ( | )) with weights = |{ : ∈ }|/ , | | denotes cardinality of set S. We refer to this as "random-pruning induced weights". Empirically, estimates based on inverse LD weighting are consistent with estimates based on random-pruning induced weights with cutoff 2 = 0.1.
SNPs in the analysis. To enable direct comparison of our model with LD score regression we use the same set of SNPs in our log likelihood optimization, which consist of approx. 1.1 million variants, subset of 1000 Genomes and HapMap3 38 , with MAF >= 0.05, ambiguous SNPs excluded, imputation INFO above 0.9, MHC and other long-range LD regions excluded. This set of SNPs is also used to calculate weights in log-likelihood optimization. Calculation of the LD scores ℓ and shape parameter are based on the approx. 10 million SNPs, available from 1000 Genomes Phase 3 data.
